vTv Therapeutics Inc.
VTVT
$33.31
$0.521.59%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.84M | 36.84M | -- | 17.00K | 17.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.84M | 36.84M | -- | 17.00K | 17.00K |
| Cost of Revenue | 28.68M | 24.01M | 17.86M | 16.19M | 12.39M |
| Gross Profit | 8.16M | 12.83M | -17.86M | -16.17M | -12.37M |
| SG&A Expenses | 17.41M | 15.87M | 14.95M | 13.65M | 13.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.09M | 39.88M | 32.81M | 29.83M | 25.64M |
| Operating Income | -9.25M | -3.04M | -32.81M | -29.82M | -25.62M |
| Income Before Tax | -6.40M | -729.00K | -31.08M | -28.38M | -23.87M |
| Income Tax Expenses | -- | -- | -- | 0.00 | 0.00 |
| Earnings from Continuing Operations | -6.40 | -0.73 | -31.08 | -28.38 | -23.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.65M | 2.98M | 4.11M | 4.91M | 4.32M |
| Net Income | -4.76M | 2.25M | -26.97M | -23.47M | -19.56M |
| EBIT | -9.25M | -3.04M | -32.81M | -29.82M | -25.62M |
| EBITDA | -9.25M | -3.03M | -32.79M | -29.78M | -25.57M |
| EPS Basic | -0.76 | -0.63 | -3.35 | -3.32 | -3.12 |
| Normalized Basic EPS | -0.40 | -0.24 | -1.87 | -1.81 | -1.69 |
| EPS Diluted | -1.06 | -0.92 | -3.35 | -3.33 | -3.12 |
| Normalized Diluted EPS | -0.58 | -0.42 | -1.87 | -1.81 | -1.69 |
| Average Basic Shares Outstanding | 45.28M | 39.46M | 33.63M | 27.81M | 25.21M |
| Average Diluted Shares Outstanding | 47.51M | 41.69M | 33.63M | 27.81M | 25.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |